The latest intelligence research report was published by Stratagem Market Overview on “Overview of Active Pharmaceutical Ingredients (API) Market 2022-2028“. The report provides a comprehensive overview of the ongoing market and clinical development in the Active Pharmaceutical Ingredients market. The report highlights global market trends and provides a detailed overview of Active Pharmaceutical Ingredients development by types, applications, regions, phase, drug class and mode of action.
The active pharmaceutical ingredient (API) produces the intended effects in a drug. A drug can contain a single API or multiple APIs for the treatment of different symptoms of a particular disease. According to the United States Food and Drug Administration, any substance or mixture of substances intended for use in the manufacture of a drug product (drug) and which, when used in the production of a drug, becomes a active ingredient of the drug product.
Download sample report for insights on drivers, trends and challenges that will help companies assess and develop growth strategies for 2022-2028
The increasing prevalence of chronic diseases is expected to drive the growth of the global active pharmaceutical ingredients market over the forecast period. For example, according to the World Health Organization, approximately 18.1 million new cases and 9.6 million deaths were recorded due to cancer worldwide in 2018. Additionally, the high incidence of cardiovascular disease (MCV) is also expected to contribute to the growth of the market. . For example, according to the American Heart Association’s 2018 Heart Disease and Stroke Statistics, approximately 92.1 million adults in the United States have some form of cardiovascular disease or the sequelae of a stroke.
API R&D is expected to provide lucrative growth opportunities for players in the global active pharmaceutical ingredients market. For example, in June 2019, Bristol-Myers Squibb researchers reported the benefits of using demographic equilibrium modeling of crystallization processes for the prediction of the particle size distribution of an API, in the journal MDPI Processes. Moreover, the development of ionic liquid APIs is also expected to contribute to the growth of the market. For example, in November 2018, researchers from the University of Vigo, Spain reported the transformation of two solid APIs, indomethacin and mebendazole, into new ionic liquid APIs.
However, stringent regulations, higher manufacturing costs and increased competition are some of the factors expected to hinder the growth of the global active pharmaceutical ingredients market. For example, in November 2019, Teva Pharmaceuticals halted production at its API plant in Italy, due to a mandate from regulatory authorities to submit new registration applications for products manufactured at the site.
Major market players are focusing on investing in API R&D to expand their product portfolio. For example, in April 2018, STA Pharmaceutical, a subsidiary of WuXi AppTec, signed an investment agreement with the Shanghai government to build a new R&D center for APIs and intermediates.
Key points to remember:
Increase in the prevalence of chronic diseases to increase the growth of the global active pharmaceutical ingredients market during the forecast period
API R&D is expected to provide lucrative growth opportunities for market players
Key players operating in the global active pharmaceutical ingredients market include-
Albemarle, Aurobindo Pharma, BASF, Bayer, Biocon, Boehringer Ingelheim GmbH, Cambrex, Cipla, Dr. Reddy Laboratories, DSM, Haerbin Pharmaceutical Group, Hisun Pharmacy, Huahai Pharmaceutical, Jiangsu Hengrui Medicine, Johnson & Johnson, Johnson Matthey, Lonza Group, Lupin, Mylan, North China Pharmaceutical Group, North East Pharmaceutical, Novartis, Pfizer, Roche, Shandong Lukang Pharmaceutical, Shandong Xinhua Pharmaceutical, STA Pharmaceutical, Sun Pharmaceutical Industries, Teva Pharmaceuticals, Tian Yao and Zhejiang Medicine.
By type, the market is mainly segmented into:
✤ Innovative active pharmaceutical ingredients ✤ Generic Active Pharmaceutical Ingredients
By apps, the market is segmented into:
✤ Oncology ✤ Cardiovascular disease ✤ Diabetes ✤ Central nervous system and neurological disorders ✤ Endocrinology ✤ Other therapeutic applications
The report covers the following regions:
➛ North America (United States, Canada and Mexico), ➛ Europe (Germany, France, United Kingdom, Russia and Italy) ➛ Asia Pacific (China, Japan, Korea, India and Southeast Asia) ➛ South America (Brazil, Argentina, Colombia, etc.) ➛ Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa)
Global Active Pharmaceutical Ingredients (API) Market Overview 2022-2028 Highlights:
✤ Innovative active pharmaceutical ingredients ✤ Generic Active Pharmaceutical Ingredients ✤ Oncology ✤ Cardiovascular disease ✤ Diabetes ✤ Central nervous system and neurological disorders ✤ Endocrinology ✤ Other therapeutic applications